LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 181 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,087,000 | +430.1% | 56,208 | +462.1% | 0.16% | +367.6% |
| Q1 2015 | $771,000 | +44.9% | 10,000 | 0.0% | 0.03% | +88.9% |
| Q4 2014 | $532,000 | +130.3% | 10,000 | +190.7% | 0.02% | +260.0% |
| Q1 2014 | $231,000 | -39.5% | 3,440 | -52.7% | 0.01% | -37.5% |
| Q4 2013 | $382,000 | -26.5% | 7,270 | -39.4% | 0.01% | +33.3% |
| Q3 2013 | $520,000 | -44.4% | 12,000 | -52.0% | 0.01% | -77.8% |
| Q2 2013 | $935,000 | – | 25,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |